Transdermal delivery of selegiline from alginate-Pluronic composite thermogels

被引:75
作者
Chen, Chih-Chieh [1 ]
Fang, Chia-Lang [2 ]
Al-Suwayeh, Saleh A. [3 ]
Leu, Yann-Lii [4 ]
Fang, Jia-You [1 ,3 ,5 ]
机构
[1] Chang Gung Univ, Pharmaceut Lab, Grad Inst Nat Prod, Tao Yuan 333, Taiwan
[2] Taipei Med Univ, Dept Pathol, Coll Med, Taipei, Taiwan
[3] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia
[4] Chang Gung Univ, Nat Prod Lab, Grad Inst Nat Prod, Tao Yuan, Taiwan
[5] Chang Gung Technol Univ, Dept Cosmet Sci, Tao Yuan, Taiwan
关键词
Transdermal delivery; Selegiline; Thermogel; Alginate; Pluronic F127; CONTROLLED-RELEASE; DRUG-DELIVERY; THERMOSENSITIVE HYDROGELS; COPOLYMER SYSTEMS; HYALURONIC-ACID; SKIN DELIVERY; IN-VITRO; TEMPERATURE; CHITOSAN; BEHAVIOR;
D O I
10.1016/j.ijpharm.2011.05.060
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The present work was carried out to design a practical, controlled-release transdermal system for selegiline using thermosensitive hydrogels. The copolymers of alginate and Pluronic F127 (PF127) were used to design thermogels by either physical blending (A + P) or chemical grafting (AP). The thermogels were characterized in terms of the sol-gel temperature, scanning electron microscopy (SEM), degradation ratio, and skin permeation behavior. The chemical grafting of alginate to PF127 could delay the sol-gel temperature from 24.1 to 30.4 degrees C, which is near the temperature of the skin surface. The gelling temperature of the physical mixture of alginate and PF127 (A + P) did not significantly differ. The porosity of the A + P structure was greater compared to that of the AP structure. AP thermogels were regularly degraded, with 60% of the gel matrix remaining after a 48-h incubation. PF127 and A + P hydrogels showed almost no degradation. The results of skin permeation across porcine skin and nude mouse skin suggested that the thermogels could produce sustained selegiline release, with AP showing the most-sustained permeation. AP hydrogels exhibited linear permeation properties for the transdermal delivery of selegiline. Inter-subject variations in skin permeation were reduced by incorporation of the thermogel. Such a thermosensitive hydrogel can be advantageous as a topical therapeutic formulation for selegiline. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 39 条
[1]
Temperature-sensitive chitosan-poly(N-isopropylacrylamide) interpenetrated networks with enhanced loading capacity and controlled release properties [J].
Alvarez-Lorenzo, C ;
Concheiro, A ;
Dubovik, AS ;
Grinberg, NV ;
Burova, TV ;
Grinberg, VY .
JOURNAL OF CONTROLLED RELEASE, 2005, 102 (03) :629-641
[2]
Transdermal penetration behaviour of drugs:: CART-clustering, QSPR and selection of model compounds [J].
Baert, Bram ;
Deconinck, Eric ;
Van Gele, Mireille ;
Slodicka, Marian ;
Stoppie, Paul ;
Bode, Samuel ;
Slegers, Guido ;
Vander Heyden, Yvan ;
Lambert, Jo ;
Beetens, Johan ;
De Spiegeleer, Bart .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (22) :6943-6955
[3]
PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release [J].
Bhattarai, N ;
Ramay, HR ;
Gunn, J ;
Matsen, FA ;
Zhang, MQ .
JOURNAL OF CONTROLLED RELEASE, 2005, 103 (03) :609-624
[4]
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy [J].
Borgia, SL ;
Regehly, M ;
Sivaramakrishnan, R ;
Mehnert, W ;
Korting, HC ;
Danker, K ;
Röder, B ;
Kramer, KD ;
Schäfer-Korting, M .
JOURNAL OF CONTROLLED RELEASE, 2005, 110 (01) :151-163
[5]
Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro [J].
Cho, KY ;
Chung, TW ;
Kim, BC ;
Kim, MK ;
Lee, JH ;
Wee, WR ;
Cho, CS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 260 (01) :83-91
[6]
Escobar-Chávez JJ, 2006, J PHARM PHARM SCI, V9, P339
[7]
Temperature-sensitive hydrogels composed of chitosan and hyaluronic acid as injectable carriers for drug delivery [J].
Fang, Jia-You ;
Chen, Jyh-Ping ;
Leu, Yann-Lii ;
Hu, Huan-Wen .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 68 (03) :626-636
[8]
Fang JY, 2008, DRUG DELIV, V15, P235, DOI [10.1080/10717540802006674, 10.1080/10717540802006674 ]
[9]
Delivery of Cisplatin from Pluronic Co-polymer Systems: Liposome Inclusion and Alginate Coupling [J].
Fang, Jia-You ;
Hsu, Shu-Hui ;
Leu, Yann-Lii ;
Hu, Jiuan-Wen .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2009, 20 (7-8) :1031-1047
[10]
Selegiline transdermal system for the treatment of major depressive disorder: An 8-week, double-blind, placebo-controlled, flexible-dose titration trial [J].
Feiger, Alan D. ;
Rickels, Karl ;
Rynn, Moira A. ;
Zimbroff, Dan L. ;
Robinson, Donald S. .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (09) :1354-1361